Dear Friend,

This year Democracy Now! is celebrating our 25th anniversary—that's 25 years of bringing you fearless, independent reporting. Since our very first broadcast in 1996, Democracy Now! has refused to take government or corporate funding, because nothing is more important to us than our editorial independence. But that means we rely on you, our audience, for support. Please donate today in honor of our 25th anniversary and help us stay on air for another 25 years. We can't do our work without you. Right now, a generous donor will even DOUBLE your gift, which means it’ll go twice as far! This is a challenging time for us all, but if you're able to make a donation, please do so today. Thank you and remember, wearing a mask is an act of love.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.


Landmark Trial on Opioid Epidemic Opens in West Virginia Federal Court

HeadlineMay 04, 2021

In West Virginia, a landmark trial kicked off in federal court Monday as local governments seek accountability from drug companies over the opioid crisis. The city of Huntington and Cabell County in West Virginia are seeking over $1 billion from the nation’s three largest drug distributors: McKesson, AmerisourceBergen and Cardinal Health. Plaintiffs say the companies flooded their communities with addictive pain medications despite their known dangers, causing a “public nuisance” and fueling the country’s devastating opioid epidemic, which has claimed hundreds of thousands of lives. If the case is successful, it could have major implications for thousands of similar lawsuits around the country, brought by cities, counties, Native American tribes and other plaintiffs.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation